Abstract
Recombinant human NAT1 and polymorphic NAT2 wild-type and mutantN-acetyltransferases (encoded byNAT2 alleles with mutations at 282/857, 191, 282/590, 341/803, 341/481/803, and 341/481) were expressed inEscherichia coli strains XA90 and/or JM105, and tested for their capacity to catalyze the metabolic activation (viaO-acetylation) of theN-hydroxy (N-OH) derivatives of 2-aminofluorene (AF), and the heterocyclic arylamine mutagens 2-amino-3-methylimidazo [4,5-f]quinoline (IQ), 2-amino-3,4-dimethyl-imidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Both NAT1 and NAT2 (including all mutant human NAT2s tested) catalyzed the metabolic activation of each of theN-hydroxyarylamines to products that bound to DNA. Metabolic activation of N-OH-AF was greater than that of the heterocyclicN-hydroxyarylamines. The relative capacity of NAT1 versus NAT2 to catalyze activation varied withN-hydroxyarylamine substrate. N-OH-MeIQx and N-OH-PhIP exhibited a relative specificity for NAT2. These results provide mechanistic support for a role of the genetic acetylation polymorphism in the metabolic activation of heterocyclic amine mutagens and carcinogens.
References
Blum M, Demierre A, Grant DM, Heim M, Meyer UA (1991) Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc Natl Acad Sci USA 88: 5237–5241
Blum M, Grant DM, McBride W, Heim M, Meyer UA (1990) Human arylamineN-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 9: 193–203
Bock CW (1992) Metabolic polymorphisms affecting activation of toxic and mutagenic arylamines. TIPS 13: 223–226
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254
Brosius J, Holy A (1984) Regulation of ribosomal RNA promoters with a syntheticlac operator. Proc Natl Acad Sci USA 81: 6929–6933
Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF (1989) Human cytochrome P-450PA (P-450IA2), the phenacetinO-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA 86: 7696–7700
Deguchi T (1992) Sequences and expression of alleles of polymorphic arylamineN-acetyltransferase of human liver. J Biol Chem 267: 18140–18147
Doll MA, Ferguson RJ, Rustan TD, Hein DW (1993) Identification and expression of two novel humanNAT2 alleles. Pharmacologist 35: 204
Dupret JM, Grant DM (1992) Site-directed mutagenesis of recombinant human arylamine N-acetyltransferase expressed inEscherichia coli. J Biol Chem 267: 7381–7385
Felton JS, Knize MG, Shen NH, Andersen BD, Bjeldanes LF, Hatch FT (1986) Identification of mutagens in cooked beef. Environ Health Perspect 67: 17–24
Gerherdsson de Verdier M, Hagman U, Peters RK, Steineck G, Övervik E (1991) Meat, cooking methods and colorectal cancer: a case-referent study in Stockholm. Int J Cancer 49: 520–525
Grant DM, Lottspeich F, Meyer UA (1989) Evidence for two closely related isozymes of arylamine N-acetyltransferase in human liver. FEBS Lett 244: 203–207
Grant DM, Blum M, Beer M, Meyer UA (1991) Monomorphic and polymorphic human arylamineN-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 39: 184–191
Grant DM, Josephy PD, Lord HL, Morrison LD (1992)Salmonella typhimurium strains expressing human arylamineN-acetyl-transferases: metabolism and mutagenic activation of aromatic amines. Cancer Res 52: 3961–3964
Hein DW (1988) Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 948: 37–66
Hein DW, Rustan TD, Doll MA, Bucher KD, Ferguson RJ, Feng Y, Furman EJ, Gray K (1992) Acetyltransferases and susceptibility to chemicals. Toxicol Lett 64/65: 123–130
Hein DW, Doll MA, Gray K, Rustan TD, Ferguson RJ (1993a) Metabolic activation ofN-hydroxy-2-aminofluorene andN-hydroxy-2-acetylaminofluorene by monomorphicN-acetyltransferase (NAT1) and polymorphicN-acetyltransferase(NAT2) in colon cytosols of hamsters congenic at theNAT2 locus. Cancer Res 53: 509–514
Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ, Grant DM (1993b) Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 14: 1633–1638
Hickman D, Risch A, Camilleri JP, Sim D (1992) Genotyping human polymorphic arylamineN-acetyltransferase: identification of new slow allotype variants. Pharmacogenetics 2: 217–226
Ilett KF, David BM, Detchon P, Castleden WM, Kwa R (1987) Acetylation phenotype in colorectal carcinoma. Cancer Res 47: 1466–1469
Lang NP, Chu DZJ, Hunter CF, Kendall DC, Flammang TJ, Kadlubar FF (1986) Role of aromatic amine acetyltransferase in colorectal cancer. Arch Surg 121: 1259–1261
Mattano SS, Land S, King CM, Weber WW (1989) Purification and biochemical characterization of hepatic arylamineN-acetyl-transferase from rapid and slow acetylator mice: identity with arylhydroxamic acidN,O-acetyltransferase andN-hydroxyarylamineO-acetyltransferase. Mol Pharmacol 35: 599–609
Minchin RF, Reeves PT, Teitel CH, McManus ME, Mojarrabi B, Ilett KF, Kadlubar FF (1992)N- andO-Acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed inCOS-1 cells. Biochem Biophys Res Commun 185: 839–844
Norrander J, Kempe T, Messing J (1983) Construction of improved M13 vectors by oligonucleotide-directed mutagenesis. Gene 26: 101–106
Ohsako S, Deguchi T (1990) Cloning and expression of cDNAs for polymorphic and monomorphic arylamineN-acetyltransferases from human liver. J Biol Chem 265: 4630–4634
Ozawa S, Abu-Zeid M, Kawakubo Y, Toyama S, Yamazoe Y, Kato R (1990) Monomorphic and polymorphic isozymes of arylamineN-acetyltransferases: purification of the isozymes and genetic basis of N-acetylation polymorphism. Carcinogenesis 11: 2137–2144
Peluso M, Castegnaro M, Malaveille C, Friesen M, Garren L, Hautefeuille A, Vineis P, Kadlubar F, Bartsch H (1991)32Postlabelling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6 phenylimidazo[4,5-b]pyridine (PhIP) as a major DNA-damaging agent. Carcinogenesis 12: 713–717
Probst MR, Blum M, Fasshauer I, D’Orazio D, Meyer UA, Wild D (1992) The role of the human acetylation polymorphism in the metabolic activation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). Carcinogenesis 13: 1713–1717
Sanger F, Niklen S, Coulson AR (1977) DNA sequencing with chain terminator inhibitors. Proc Natl Acad Sci USA 74: 5463–5467
Sugimura T (1988) New environmental carcinogens in daily life. TIPS 9: 205–209
Trinidad A, Hein DW, Rustan TD, Ferguson RJ, Miller LS, Bucher KD, Kirlin WG, Ogolla F, Andrews AF (1990) Purification of hepatic polymorphic arylamineN-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphicN-hydroxyarylamineO-acetyltransferase. Cancer Res 50: 7942–7949
Turesky R, Lang NP, Butler MA, Teitel CH, Kadlubar FF (1991) Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 12: 1839–1845
Vatsis KP, Martell KJ, Weber WW (1991) Diverse point mutations in the human gene for polymorphicN-acetyltransferase. Proc Natl Acad Sci USA 88: 6333–6337
Weber WW, Hein DW (1985)N-Acetylation pharmacogenetics. Pharmacol Rev 37: 25–79
Wohlleb JC, Hunter CF, Blass B, Kadlubar FF, Chu DZJ, Lang ND (1990) Aromatic amine acetyltransferase as a marker for colorectal cancer: environmental and demographic associations. Int J Cancer 46: 22–30
Yamashita M, Wakabayashi K, Nagao M, Sato S, Yamaizumi Z, Takahashi M, Kinae N, Tomita I, Sugimura T (1986) Detection of 2-amino-3-methylimidazo[4,5-f]quinoline in cigarette smoke condensate. Jpn J Cancer Res 77: 419–422
Yanisch-Perron C, Vieira J, Messing J (1985) Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33: 103–119
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hein, D.W., Rustan, T.D., Ferguson, R.J. et al. Metabolic activation of aromatic and heterocyclicN-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Arch Toxicol 68, 129–133 (1994). https://doi.org/10.1007/s002040050045
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002040050045